Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 29, 2006

View Archived Issues

Targeting IGF-1R shows antitumor efficacy in mouse models of lung cancer

Ruboxistaurin reduces the risk of vision loss in diabetic retinopathy

Licorice component protects mice against DMN-induced lung and colon tumors

Efficacy of targeting the adenosine A3 receptor shown in patients with rheumatoid arthritis

Targets in nephrology

Novel preclinical data on Zyflamend's antitumor mechanism

Davanat studied in phase II first-line colorectal cancer study

GV-1001 begins phase II trial in liver cancer

FDA accepts complete response for Factive in five-day treatment of CAP

QSC-001 begins clinical program

Kamada begins phase I trials with inhaled API product for congenital emphysema

Neose receives milestone payment under Factor VIIa agreement with Novo Nordisk

Biota and Boehringer Ingelheim enter HCV licensing agreement

First generic ondansetron injection products approved in U.S.

Lundbeck and Biotie sign agreement for nalmefene

Novartis presents pipeline review

No reported increase in Tamiflu resistance

Cytokinetics and GSK amend license and collaboration agreement

Biocon working towards launch of antiarthritis drug in India

New pivotal study begins for Clolar in adult AML

Enrollment complete in phase II trial of MitoQ in Parkinson's disease

Sankyo patents novel compounds for transplant rejection, autoimmune diseases, etc.

Novel Rho kinase inhibitors revealed in D. Western Therapeutics patents

TRK-820 filed in Japan for severe uremic pruritus in hemodialysis patients

Recent patents disclose novel agents with potential in the treatment of HCV infection

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
Psychedelic space expanding on Trump’s EO
BioWorld
Timothy Leary is dead, but he could be on the outside looking in with a smile on his face as U.S. President Donald Trump’s latest executive order (EO) fuels a...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...